MKSAP 17 Audio Companion - Gastroenterology

• MKSAP_17_Audio_Companion_Gastroenterology_Hepatology.pdf
• 1-01 Introduction to Gastroenterology Section.m4a
• 1-02 Dysphagia.m4a
• 1-03 Oropharyngeal Dysphagia.m4a
• 1-04 Esophageal Dysphagia.m4a
• 1-05 Reflux and Chest Pain.m4a
• 1-06 Odynophagia and Globus Sensation.m4a
• 1-07 Question Break 1 A 51-year-old Woman is Evaluated in the ED After a Car Accident.m4a
• 1-08 Esophageal Motility Disorders.m4a
• 1-09 Achalasia and Pseudoachalasia.m4a
• 1-10 Treatment.m4a
• 1-11 Diffuse Esophageal Spasm and Nutcracker Esophagus.m4a
• 1-12 Hypotonic Motility Disorders.m4a
• 1-13 Infectious Esophagitis.m4a
• 1-14 Pill-Induced Esophagitis.m4a
• 1-15 Question Break 2 A 31-year-old Woman is Seen for Episodic Attacks of Idiopathic Pancreatitis.m4a
• 1-16 Eosinophilic Esophagitis.m4a
• 1-17 Treatment.m4a
• 1-18 Gastroesophageal Reflux Disease.m4a
• 1-19 Diagnosis of GERD.m4a
• 1-20 Treatment of GERD.m4a
• 1-21 Lifestyle Changes and Medical Therapy.m4a
• 1-22 Antireflux Surgery.m4a
• 1-23 Endoscopic Therapy.m4a
• 1-24 Extraesophageal Manifestations.m4a
• 1-25 Refractory Gastroesophageal Reflux Disease.m4a
• 1-26 Session 1 Key Points.m4a
• 1-27 Close to Session 1.m4a
• 2-01 Introduction to Session 2.m4a
• 2-02 Epidemiology and Screening of Barrett Esophagus.m4a
• 2-03 Diagnosis and Management.m4a
• 2-04 Epidemiology of Esophageal Carcinoma.m4a
• 2-05 Risk Factors, Diagnosis and Staging.m4a
• 2-06 Clinical Features, Diagnosis, and Complications of Peptic Ulcer Disease.m4a
• 2-07 Management.m4a
• 2-08 Question Break 3 A 58-year-old Woman is Seen for Nausea and Abdominal Pain.m4a
• 2-09 Clinical Features of Dyspepsia.m4a
• 2-10 Management.m4a
• 2-11 Treatment.m4a
• 2-12 Indications for Helicobacter pylori Testing.m4a
• 2-13 Diagnosis.m4a
• 2-14 Treatment.m4a
• 2-15 Eradication Testing.m4a
• 2-16 Question Break 4 A 48-year-old Woman is Evaluated for a 3-Month History of Anorexia.m4a
• 2-17 Miscellaneous Gastropathy.m4a
• 2-18 Eosinophilic Gastritis and Lymphocytic Gastritis.m4a
• 2-19 Gastrointestinal Complications of Common Drugs.m4a
• 2-20 Prevention of NSAID-Induced Injury.m4a
• 2-21 Session 2 Key Points.m4a
• 2-22 Close to Session 2.m4a
• 3-01 Introduction to Session 3.m4a
• 3-02 Diagnosis of Gastroparesis.m4a
• 3-03 Testing.m4a
• 3-04 Management.m4a
• 3-05 Gastric Polyps.m4a
• 3-06 Gastric Subepithelial Lesions.m4a
• 3-07 Gastrointestinal Stromal Tumors.m4a
• 3-08 Gastric Carcinoid Tumors.m4a
• 3-09 Epidemiology and Risk Factors of Gastric Adenocarcinoma.m4a
• 3-10 Question Break 5 A 70-year-old Man is Evaluated in Follow-Up for Heartburn.m4a
• 3-11 Complications of Gastric Surgical Procedures.m4a
• 3-12 Nutritional and Endocrine-Related Complications.m4a
• 3-13 Question Break 6 A 23-year-old man is Evaluated for Chronic Diarrhea.m4a
• 3-14 Acute Pancreatitis.m4a
• 3-15 Clinical Presentation and Diagnosis.m4a
• 3-16 Prognostic Criteria.m4a
• 3-17 Management.m4a
• 3-18 Complications.m4a
• 3-19 Chronic Pancreatitis.m4a
• 3-20 Clinical Presentation and Diagnosis.m4a
• 3-21 Management.m4a
• 3-22 Session 3 Key Points.m4a
• 3-23 Close to Session 3.m4a
• 4-01 Introduction to Session 4.m4a
• 4-02 Pancreatic Adenocarcinoma.m4a
• 4-03 Clinical Presentation.m4a
• 4-04 Diagnosis and Staging.m4a
• 4-05 Ampullary Adenocarcinoma and Autoimmune Pancreatitis and IgG4 Disease.m4a
• 4-06 Clinical Presentation and Diagnosis.m4a
• 4-07 Treatment.m4a
• 4-08 Cystic Neoplasms of the Pancreas.m4a
• 4-09 Pancreatic Neuroendocrine Tumors.m4a
• 4-10 Question Break 7 A 23-year-old woman is Seen for Alternating Diarrhea and Constipation.m4a
• 4-11 Characterization of Diarrhea.m4a
• 4-12 Evaluation and Management.m4a
• 4-13 Subclassification of Diarrhea.m4a
• 4-14 Malabsorption and Celiac Disease.m4a
• 4-15 Question Break 8 A 25-year-old Woman is Seen for Epigastric Abdominal Pain.m4a
• 4-16 Small Intestinal Bacterial Overgrowth.m4a
• 4-17 Short-Bowel Syndrome.m4a
• 4-18 Carbohydrate Malabsorption.m4a
• 4-19 Inflammatory Bowel Disease.m4a
• 4-20 Ulcerative Colitis.m4a
• 4-21 Session 4 Key Points.m4a
• 4-22 Close to Session 4.m4a
• 5-01 Introduction to Session 5.m4a
• 5-02 Crohn Disease.m4a
• 5-03 Extraintestinal Manifestations.m4a
• 5-04 Diagnosis of IBD.m4a
• 5-05 Treatment of IBD.m4a
• 5-06 Treatment of Ulcerative Colitis.m4a
• 5-07 Aminosalicylate Preparations for the Treatment of UC.m4a
• 5-08 Question Break 9 A 38-year-old woman is Seen for Abdominal Pain, Diarrhea, and Bloating.m4a
• 5-09 Treatment of Crohn Disease.m4a
• 5-10 Health Maintenance for the Patient with IBD.m4a
• 5-11 Microscopic Colitis.m4a
• 5-12 Question Break 10 A 55-year-old Woman is Seen after Biliopancreatic Diversion with Duodenal Switch Surgery.m4a
• 5-13 Constipation.m4a
• 5-14 Classification.m4a
• 5-15 Evaluation.m4a
• 5-16 Treatment.m4a
• 5-17 Irritable Bowel Syndrome.m4a
• 5-18 Evaluation.m4a
• 5-19 Management.m4a
• 5-20 Therapy for IBS-C and -D.m4a
• 5-21 Other Therapies.m4a
• 5-22 Session 5 Key Points.m4a
• 5-23 Close to Session 5.m4a
• 6-01 Introduction to Session 6.m4a
• 6-02 Diverticular Disease and Ischemic Bowel Disease.m4a
• 6-03 Acute Mesenteric Ischemia.m4a
• 6-04 Treatment.m4a
• 6-05 Chronic Mesenteric Ischemia.m4a
• 6-06 Colonic Ischemia.m4a
• 6-07 Treatment.m4a
• 6-08 Perianal Disorders and Hemorrhoids.m4a
• 6-09 Question Break 11 A 34-year-old Woman is Seen after a Recent Diagnosis of Hepatitis C Virus Infection.m4a
• 6-10 Anal Fissure and Fecal Incontinence.m4a
• 6-11 Anal Cancer.m4a
• 6-12 Colorectal Neoplasia.m4a
• 6-13 Pathogenesis.m4a
• 6-14 Predisposing Factors.m4a
• 6-15 Question Break 12 A 58-year-old woman is Evaluated for Progressive Fatigue and Generalized Pruritus.m4a
• 6-16 Hereditary Colon Cancer Syndromes.m4a
• 6-17 Hereditary Nonpolyposis Colon Cancer.m4a
• 6-18 Adenomatous Polyposis Syndromes.m4a
• 6-19 Peutz-Jeghers Syndrome and Juvenile Polyposis Syndrome.m4a
• 6-20 PTEN Hamartoma Tumor Syndrome and Serrated Polyposis Syndrome.m4a
• 6-21 Screening.m4a
• 6-22 Chemoprevention.m4a
• 6-23 Session 6 Key Points.m4a
• 6-24 Close to Session 6.m4a
• 7-01 Introduction to Session 7.m4a
• 7-02 Clinical Presentation, Diagnosis and Staging.m4a
• 7-03 Postpolypectomy Surveillance.m4a
• 7-04 History of Colorectal Cancer.m4a
• 7-05 Hereditary Nonpolyposis Colon Cancer.m4a
• 7-06 Ulcerative or Crohn Colitis.m4a
• 7-07 Peutz-Jeghers and Other Syndromes.m4a
• 7-08 Approach to the Patient with Abnormal Liver Chemistry Studies.m4a
• 7-09 Assessing Liver Function.m4a
• 7-10 Hepatitis A.m4a
• 7-11 Hepatitis B.m4a
• 7-12 Interpretation of Hepatitis B Test Results.m4a
• 7-13 Phases of Chronic HBV.m4a
• 7-14 Treatment.m4a
• 7-15 Hepatitis C.m4a
• 7-16 Treatment.m4a
• 7-17 Hepatitis D and E.m4a
• 7-18 Other Viruses That Affect the Liver.m4a
• 7-19 Alcohol-Induced Liver Disease.m4a
• 7-20 Drug-Induced Liver Injury.m4a
• 7-21 Diagnosis and Management of DILI.m4a
• 7-22 Diagnostic Testing.m4a
• 7-23 Acute Liver Failure.m4a
• 7-24 Autoimmune Hepatitis.m4a
• 7-25 Session 7 Key Points.m4a
• 7-26 Close to Session 7.m4a
• 8-01 Introduction to Session 8.m4a
• 8-02 Nonalcoholic Fatty Liver Disease.m4a
• 8-03 Hereditary Hemochromatosis.m4a
• 8-05 Primary Biliary Cirrhosis.m4a
• 8-06 Primary Sclerosing Cholangitis.m4a
• 8-07 Determining Prognosis in Patients With Cirrhosis.m4a
• 8-08 Complications of Advanced Liver Disease and Portal Hypertension.m4a
• 8-09 Esophageal Varices.m4a
• 8-10 Management.m4a
• 8-11 Gastric Varices and Portal Hypertensive Gastropathy.m4a
• 8-12 Hepatic Encephalopathy.m4a
• 8-13 Hepatopulmonary Syndrome and Portopulmonary Hypertension.m4a
• 8-14 Ascites.m4a
• 8-15 Spontaneous Bacterial Peritonitis.m4a
• 8-16 Hepatorenal Syndrome.m4a
• 8-17 Hepatic Osteodystrophy.m4a
• 8-18 Immunizations.m4a
• 8-19 Avoidances and Nutritional Issues.m4a
• 8-20 Hepatic Tumors, Cysts, and Abscesses.m4a
• 8-21 Focal Nodular Hyperplasia and Hepatocellular Adenoma.m4a
• 8-22 Hepatic Hemangioma, Hepatic Abscesses and Amebiasis.m4a
• 8-23 Session 8 Key Points.m4a
• 8-24 Close to Session 8.m4a
• 9-01 Introduction to Session 9.m4a
• 9-02 Hepatocellular Carcinoma.m4a
• 9-03 Liver Transplantation.m4a
• 9-04 Pregnancy-Related Liver Disease.m4a
• 9-05 Portal Vein Thrombosis and Budd-Chiari Syndrome.m4a
• 9-06 Asymptomatic Gallstones.m4a
• 9-07 Biliary Colic and Acute Cholecystitis.m4a
• 9-08 Acalculous Cholecystitis, Common Bile Duct Stones and Cholangitis.m4a
• 9-09 Gallbladder Cancer.m4a
• 9-10 Cholangiocarcinoma.m4a
• 9-11 Upper Gastrointestinal Bleeding.m4a
• 9-12 Evaluation of Acute GI Bleeding.m4a
• 9-13 Management.m4a
• 9-14 Endoscopic Evaluation and Treatment.m4a
• 9-15 Postendoscopic Care and Risk Reduction.m4a
• 9-16 Lower Gastrointestinal Bleeding.m4a
• 9-17 Evaluation and Initial Management.m4a
• 9-18 Other Management Strategies.m4a
• 9-19 Obscure Gastrointestinal Bleeding.m4a
• 9-20 Causes of Obscure Gastrointestinal Bleeding.m4a
• 9-21 Evaluation of Obscure GI Bleeding.m4a
• 9-22 Technetium-Labeled Nuclear Scan, Angiography and Wireless Capsule Endoscopy.m4a
• 9-23 Push Enteroscopy and Spiral Enteroscopy.m4a
• 9-24 Single- and Double-Balloon Enteroscopy and Small-Bowel Radiography.m4a
• 9-25 Management.m4a
• 9-26 Session 9 Key Points.m4a
• 9-27 Close to Gastroenterology Section.m4a